Servicio de Oncología Médica, Centro Integral Oncológico Clara Campal, Madrid, Spain.
Clin Transl Oncol. 2010 Jan;12(1):32-42. doi: 10.1007/s12094-010-0464-1.
Breast cancer treatment currently requires the joint efforts of a multidisciplinary team to effectively combine chemotherapy, hormone therapy, biological agents, surgery and radiation therapy when needed. To develop such a treatment plan, it is important to know the benefits as well as the potential toxic effects of each therapy. Thus, many patients with early breast cancer complain of collateral adverse events such as fatigue, nausea, vomiting, loss of libido, hot flashes, night sweats or neuropathy due to the complex therapies they are receiving. To date, the treatment of such symptoms is an important issue that greatly affects the quality of life of these patients. In this review, we report the content of a multi-expert meeting where the incidence of and medical approach to some of the most common adverse events encountered during the treatment of patients with early breast cancer were analysed.
目前，乳腺癌的治疗需要多学科团队的共同努力，在需要时有效结合化疗、激素治疗、生物制剂、手术和放疗。为了制定这样的治疗计划，了解每种治疗方法的益处以及潜在的毒副作用非常重要。因此，许多早期乳腺癌患者由于接受了复杂的治疗，会出现疲劳、恶心、呕吐、性欲减退、热潮红、盗汗或神经病变等不良反应。迄今为止，治疗这些症状是一个重要的问题，极大地影响了这些患者的生活质量。在本次综述中，我们报告了一次多专家会议的内容，对早期乳腺癌患者治疗过程中遇到的一些最常见的不良反应的发生率和医疗方法进行了分析。
